Focus: Renata Medical is a newly founded (2024) medical device company specializing in stents for pediatric vascular stenosis, based in Newport Beach, CA. The company operates in the cardiovascular device segment with a focus on rare, high-acuity infant conditions.
Profile data last refreshed 17h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow Renata Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Generic post-LOE product with no current revenue data; likely legacy or non-core asset misaligned with company's stated cardiovascular device focus.
Help build intelligence for Renata Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Renata Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Generic diuretic post-LOE with no current revenue; presence suggests prior pharma operations or asset acquisition unrelated to core device strategy.
Generic statin post-LOE with no revenue disclosures; indicates prior pharmaceutical diversification now presumably divested or dormant.
Generic beta-blocker post-LOE; represents legacy pharma portfolio with no active revenue contribution to company strategy.
Generic triptan post-LOE with no revenue; legacy pharmaceutical asset unrelated to stated cardiovascular device mission.
No open positions listed yet.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo